TITLE 9. HEALTH SERVICES

CHAPTER 6. DEPARTMENT OF HEALTH SERVICES
COMMUNICABLE DISEASES AND INFESTATIONS

ARTICLE 1. GENERAL

Section

R9-6-101. Definitions

R9-6-102. Release of Protected Health Information

R9-6-103. Renumbered

R9-6-104. Repealed

R9-6-105. Renumbered

R9-6-106. Renumbered

Exhibit I-A. Case Definitions for Suspected Clinically Significant Adverse Events

R9-6-107. Repealed

R9-6-108. Renumbered

R9-6-109. Reserved

R9-6-110. Reserved

R9-6-111. Repealed

R9-6-112. Renumbered

R9-6-113. Repealed

R9-6-114. Repealed

ARTICLE 2. COMMUNICABLE DISEASE AND INFESTATION REPORTING

Article 2, consisting of Section R9-6-201 and R9-6-202, renumbered from Article 6, Sections R9-6-601 and R9-6-602 effective October 19, 1993 (Supp. 93-4).

Article 2, consisting of Sections R9-6-201 through R9-6-203, renumbered to Article 5, Sections R9-6-501 through R9-6-503 effective October 19, 1993 (Supp. 93-4).

Section

R9-6-201. Definitions

R9-6-202. Reporting Requirements for a Health Care Provider Required to Report or an Administrator of a Health Care Institution or Correctional Facility

Table 1. Reporting Requirements for a Health Care Provider Required to Report or an Administrator of a Health Care Institution or Correctional Facility

R9-6-203. Reporting Requirements for an Administrator of a School, Child Care Establishment, or Shelter

Table 2. Reporting Requirements for an Administrator of a School, Child Care Establishment, or Shelter

R9-6-204. Clinical Laboratory Director Reporting Requirements

Table 3. Clinical Laboratory Director Reporting Requirements

R9-6-205. Reporting Requirements for a Pharmacist or Pharmacy Administrator

R9-6-206. Local Health Agency Responsibilities Regarding Communicable Disease Reports

Table 4. Local Health Agency Reporting Requirements

R9-6-207. Federal or Tribal Entity Reporting

R9-6-208. Reserved

R9-6-209. Reserved

R9-6-210. Reserved

R9-6-211. Renumbered

R9-6-212. Renumbered

R9-6-213. Renumbered

R9-6-214. Renumbered

ARTICLE 3. CONTROL MEASURES FOR COMMUNICABLE DISEASES AND INFESTATIONS

Article 3, consisting of Sections R9-6-302 through R9-6-307, R9-6-309 through R9-6-311, R9-6-313, R9-6-315 through R9-6-317, R9-6-319 through R9-6-325, R9-6-327, R9-6-328, R9-6-330 through R9-6-356, and R9-6-358 through R9-6-366, renumbered from Article 7, Sections R9-6-701 through R9-6-746 and R9-6-748 through R9-6-759 effective October 19, 1993 (Supp. 93-4).

Article 3, consisting of Section R9-6-311, repealed (Supp. 91-2).

Section

R9-6-301. Definitions

R9-6-302. Local Health Agency Control Measures

R9-6-303. Isolation and Quarantine

R9-6-304. Food Establishment Control Measures

R9-6-305. Amebiasis

R9-6-306. Anthrax

R9-6-307. Aseptic Meningitis

R9-6-308. Basidiobolomycosis

R9-6-309. Botulism

R9-6-310. Brucellosis

R9-6-311. Campylobacteriosis

R9-6-312. Chagas Infection and Related Disease (American Trypanosomiasis)

R9-6-313. Chancroid (Haemophilus ducreyi)

R9-6-314. Chlamydia Infection, Sexually Transmitted

R9-6-315. Cholera

R9-6-316. Coccidioidomycosis (Valley Fever)

R9-6-317. Colorado Tick Fever

R9-6-318. Conjunctivitis: Acute

R9-6-319. Creutzfeldt-Jakob Disease

R9-6-320. Cryptosporidiosis

R9-6-321. Cyclospora Infection

R9-6-322. Cysticercosis

R9-6-323. Dengue

R9-6-324. Diarrhea, Nausea, or Vomiting

R9-6-325. Diphtheria

R9-6-326. Ehrlichioses (Ehrlichiosis and Anaplasmosis)

R9-6-327. Emerging or Exotic Disease

R9-6-328. Encephalitis: Viral or Parasitic

R9-6-329. Enterohemorrhagic Escherichia coli

R9-6-330. Enterotoxigenic Escherichia coli

R9-6-331. Giardiasis

R9-6-332. Gonorrhea

R9-6-333. Haemophilus influenzae: Invasive Disease

R9-6-334. Hansen's Disease (Leprosy)

R9-6-335. Hantavirus Infection

R9-6-336. Hemolytic Uremic Syndrome

R9-6-337. Hepatitis A

R9-6-338. Hepatitis B and Hepatitis D

R9-6-339. Hepatitis C

R9-6-340. Hepatitis E

R9-6-341. Human Immunodeficiency Virus (HIV) Infection and Related Disease

R9-6-342. Influenza-Associated Mortality in a Child

R9-6-343. Kawasaki Syndrome

R9-6-344. Legionellosis (Legionnaires' Disease)

R9-6-345. Leptospirosis

R9-6-346. Listeriosis

R9-6-347. Lyme Disease

R9-6-348. Lymphocytic Choriomeningitis

R9-6-349. Malaria

R9-6-350. Measles (Rubeola)

R9-6-351. Melioidosis

R9-6-352. Meningococcal Invasive Disease

R9-6-353. Mumps

R9-6-354. Norovirus

R9-6-355. Pediculosis (Lice Infestation)

R9-6-356. Pertussis (Whooping Cough)

R9-6-357. Plague

R9-6-358. Poliomyelitis

R9-6-359. Psittacosis (Ornithosis)

R9-6-360. Q Fever

R9-6-361. Rabies in a Human

R9-6-362. Relapsing Fever (Borreliosis)

R9-6-363. Reye Syndrome

R9-6-364. Rocky Mountain Spotted Fever

R9-6-365. Rubella (German Measles)

R9-6-366. Rubella Syndrome, Congenital

R9-6-367. Salmonellosis

R9-6-368. Scabies

R9-6-369. Severe Acute Respiratory Syndrome

R9-6-370. Shigellosis

R9-6-371. Smallpox

R9-6-372. Streptococcal Group A Infection

R9-6-373. Streptococcal Group B Infection in an Infant Younger than 90 Days of Age

R9-6-374. Streptococcus pneumoniae Infection

R9-6-375. Syphilis

R9-6-376. Taeniasis

R9-6-377. Tetanus

R9-6-378. Toxic Shock Syndrome

R9-6-379. Trichinosis

R9-6-380. Tuberculosis

R9-6-381. Tularemia

R9-6-382. Typhoid Fever

R9-6-383. Typhus Fever

R9-6-384. Unexplained Death with a History of Fever

R9-6-385. Vaccinia-related Adverse Event

R9-6-386. Vancomycin-Resistant or Vancomycin-Intermediate Staphylococcus aureus

R9-6-387. Vancomycin-Resistant Staphylococcus epidermidis

R9-6-388. Varicella (Chickenpox)

R9-6-389. Vibrio Infection

R9-6-390. Viral Hemorrhagic Fever

R9-6-391. West Nile Virus-related Syndromes

R9-6-392. Yellow Fever

R9-6-393. Yersiniosis (Enteropathogenic Yersinia)

R9-6-394. Preservation When Death Caused by Certain Diseases

Exhibit III-A. Repealed

Exhibit III-B. Repealed

Exhibit III-C. Repealed

Exhibit III-D. Repealed

Exhibit III-E. Repealed

Exhibit III-F. Repealed

Exhibit III-G. Repealed

Exhibit III-H. Repealed

Exhibit III-I. Repealed

Exhibit III-J. Repealed

Exhibit III-K. Repealed

Exhibit III-L. Repealed

Exhibit III-M. Repealed

Exhibit III-N. Repealed

ARTICLE 4. AIDS DRUG ASSISTANCE PROGRAM (ADAP)

Article 4, consisting of Sections R9-6-401 through R9-6-408, renumbered from Article 8, Sections R9-6-801 through R9-6-808 effective October 19, 1993 (Supp. 93-4).

Article 4, consisting of Sections R9-6-411 through R9-6-419 and R9-6-431 through R9-6-433, repealed effective October 19, 1993 (Supp. 93-4).

Section

R9-6-401. Definitions

R9-6-402. Limitations and Termination of Program

R9-6-403. Eligibility Requirements

R9-6-404. Initial Application Process

R9-6-405. Enrollment Process; Provisional Enrollment

R9-6-406. Notification Requirements

R9-6-407. Continuing Enrollment

R9-6-408. Termination from ADAP Services

R9-6-409. Drug Prescription and Distribution Requirements

Exhibit A. Renumbered

Exhibit B. Renumbered

R9-6-410. Confidentiality

R9-6-411. Repealed

R9-6-412. Repealed

R9-6-413. Repealed

R9-6-414. Repealed

R9-6-415. Repealed

R9-6-416. Repealed

R9-6-417. Repealed

R9-6-418. Repealed

R9-6-419. Repealed

R9-6-420. Reserved

R9-6-421. Reserved

R9-6-422. Reserved

R9-6-423. Reserved

R9-6-424. Reserved

R9-6-425. Reserved

R9-6-426. Reserved

R9-6-427. Reserved

R9-6-428. Reserved

R9-6-429. Reserved

R9-6-430. Reserved

R9-6-431. Repealed

R9-6-432. Repealed

R9-6-433. Repealed

ARTICLE 5. RABIES CONTROL

Article 5, consisting of Sections R9-6-501 through R9-6-503, renumbered from Article 2, Sections R9-6-201 through R9-6-203 effective October 19, 1993 (Supp. 93-4).

Article 5, consisting of Sections R9-6-501 through R9-6-506 and Tables 1 and 2, renumbered to Article 7, Sections R9-6-701 through R9-6-706 and Tables 1 and 2 effective October 19, 1993 (Supp. 93-4).

Article 5, consisting of Sections R9-6-501 through R9-6-506 and Tables 1 and 2, adopted effective January 20, 1992 (Supp. 92-1).

Article 5, consisting of Sections R9-6-501 through R9-6-504, repealed effective January 20, 1992 (Supp. 92-1).

Section

R9-6-501. Definitions

R9-6-502. Management of Exposed Animals

R9-6-503. Suspect Cases

R9-6-504. Animal Control Agency Reporting Requirements

R9-6-505. Renumbered

R9-6-506. Renumbered

Table 1. Renumbered

Table 2. Renumbered

ARTICLE 6. REPORTING POST-EXPOSURE RABIES PROPHYLAXIS

Article 6, consisting of Sections R9-6-601 through R9-6-603, adopted effective October 19, 1993 (Supp. 93-4).

Article 6, Sections R9-6-601 and R9-6-602, renumbered to Article 2, Sections R9-6-201 and R9-6-202, and Article 6, Sections R9-6-602 through R9-6-605 repealed effective October 19, 1993 (Supp. 93-4).

Section

R9-6-601. Reporting Requirements

R9-6-602. Renumbered

R9-6-603. Renumbered

R9-6-604. Renumbered

R9-6-605. Repealed

R9-6-606. Emergency Expired

ARTICLE 7. REQUIRED IMMUNIZATIONS FOR CHILD CARE OR SCHOOL ENTRY

Article 7, consisting of Sections R9-6-701 through R9-6-706, renumbered from Article 5 effective October 19, 1993 (Supp. 93-4).

Article 7 renumbered to Article 3 effective October 19, 1993 (Please refer to the individual Sections for the appropriate actions and new locations) (Supp. 93-4).

Section

R9-6-701. Definitions

R9-6-702. Required Immunizations for Child Care or School Entry

R9-6-703. Responsibilities of Individuals and Local Health Agencies for Administering Vaccines

R9-6-704. Standards for Documentary Proof of Immunity

R9-6-705. Responsibilities of Schools and Child Care

R9-6-706. Exemptions from Immunizations

Table 1. Renumbered

Table 2. Renumbered

R9-6-707. Reporting Requirements

Table 1. Immunization Requirements for Child Care or School Entry

Table 2. Catch-up Immunization Schedule for Child Care or School Entry

R9-6-708. Release of Immunization Information

R9-6-709. Renumbered

R9-6-710. Renumbered

R9-6-711. Renumbered

R9-6-712. Renumbered

R9-6-713. Renumbered

R9-6-714. Renumbered

R9-6-715. Renumbered

R9-6-716. Renumbered

R9-6-717. Renumbered

R9-6-718. Renumbered

R9-6-719. Renumbered

R9-6-720. Renumbered

R9-6-721. Renumbered

R9-6-722. Renumbered

R9-6-723. Renumbered

R9-6-724. Renumbered

R9-6-725. Renumbered

R9-6-726. Renumbered

R9-6-727. Renumbered

R9-6-728. Renumbered

R9-6-729. Renumbered

R9-6-730. Renumbered

R9-6-731. Renumbered

R9-6-732. Renumbered

R9-6-733. Renumbered

R9-6-734. Renumbered

R9-6-735. Renumbered

R9-6-736. Renumbered

R9-6-737. Renumbered

R9-6-738. Renumbered

R9-6-739. Renumbered

R9-6-740. Renumbered

R9-6-741. Renumbered

R9-6-742. Renumbered

R9-6-743. Renumbered

R9-6-744. Renumbered

R9-6-745. Renumbered

R9-6-746. Renumbered

R9-6-747. Repealed

R9-6-748. Renumbered

R9-6-749. Renumbered

R9-6-750. Renumbered

R9-6-751. Renumbered

R9-6-752. Renumbered

R9-6-753. Renumbered

R9-6-754. Renumbered

R9-6-755. Renumbered

R9-6-756. Renumbered

R9-6-757. Renumbered

R9-6-758. Renumbered

R9-6-759. Renumbered

ARTICLE 8. ASSAULTS ON PUBLIC SAFETY EMPLOYEES AND VOLUNTEERS

New Article 8, consisting of Sections R9-6-801 through R9-6-803, made by final rulemaking at 8 A.A.R. 5214, effective February 1, 2003 (Supp. 02-4).

Article 8, consisting of Sections R9-6-801 through R9-6-808, renumbered to Article 4, Sections R9-6-401 through R9-6-408 (Supp. 93-4).

Article 8 consisting of Sections R9-6-801 through R9-6-808 adopted as permanent rules effective May 22, 1989.

Article 8 consisting of Sections R9-6-801 through R9-6-808 readopted as an emergency effective November 16, 1988, pursuant to A.R.S. § 41-1026, valid for only 90 days. Emergency expired.

Article 8 consisting of Sections R9-6-801 through R9-6-808 readopted as an emergency effective August 8, 1988, pursuant to A.R.S. § 41-1026, valid for only 90 days. Emergency expired.

Article 8 consisting of Sections R9-6-801 through R9-6-809 readopted as an emergency effective May 9, 1988, pursuant to A.R.S. § 41-1026, valid for only 90 days.

Article 8 consisting of Sections R9-6-801 through R9-6-809 adopted as an emergency effective January 12, 1988, pursuant to A.R.S. § 41-1026, valid for only 90 days. Emergency expired.

Section

R9-6-801. Definitions

R9-6-802. Notice of Test Results

R9-6-803. Repealed

R9-6-804. Renumbered

R9-6-805. Renumbered

R9-6-806. Renumbered

R9-6-807. Renumbered

R9-6-808. Renumbered

ARTICLE 9. HEALTH PROFESSIONAL EXPOSURES

Article 9, consisting of Sections R9-6-901 through R9-6-903 and Exhibits A and B, recodified to Article 10, Sections R9-6-1001 through R9-6-1003 and Exhibits A and B, at 13 A.A.R. 1745, effective April 27, 2007 (Supp. 07-2).

Article 9, consisting of Sections R9-6-901 through R9-6-903 and Exhibits A and B, made by final rulemaking at 8 A.A.R. 1953, effective April 3, 2002 (Supp. 02-2).

Section

R9-6-901. Definitions

R9-6-902. Notice of Test Results

Exhibit A. Recodified

Exhibit B. Recodified

R9-6-903. Recodified

ARTICLE 10. HIV-RELATED TESTING AND NOTIFICATION

Article 10, consisting of Sections R9-6-1001 through R9-6-1003 and Exhibits A and B, recodified from Article 9, Sections R9-6-901 through R9-6-903 and Exhibits A and B, at 13 A.A.R. 1745, effective April 27, 2007 (Supp. 07-2).

Section

R9-6-1001. Definitions

R9-6-1002. Local Health Agency Requirements

R9-6-1003. Consent for HIV-related Testing

Exhibit A. HIV-related Test Information and Consent Form

Exhibit B. Repealed

R9-6-1004. Court-ordered HIV-related Testing

R9-6-1005. Anonymous HIV Testing

R9-6-1006. Notification

ARTICLE 11. STD-RELATED TESTING AND NOTIFICATION

Article 11, consisting of Sections R9-6-1101 through R9-6-1104 made by final rulemaking at 14 A.A.R.1502, effective April 1, 2008 (Supp. 08-2).

Section

R9-6-1101. Definitions

R9-6-1102. Health Care Provider Requirements

R9-6-1103. Local Health Agency Requirements

R9-6-1104. Court-ordered STD-related Testing

ARTICLE 12. TUBERCULOSIS CONTROL

Article 12, consisting of Sections R9-6-1201 through R9-6-1204, renumbered from Article 6, Sections R9-6-601 through R9-6-604, by final rulemaking at 13 A.A.R. 4106, effective January 5, 2008 (Supp. 07-4).

Section

R9-6-1201. Definitions

R9-6-1202. Local Health Agency Reporting Requirements

R9-6-1203. Tuberculosis Control in Correctional Facilities

R9-6-1204. Standards of Medical Care

ARTICLE 1. GENERAL

R9-6-101. Definitions

In this Chapter, unless otherwise specified:

1. "Active tuberculosis" means the same as in A.R.S. § 36-711.

2. "Administrator" means the individual who is the senior leader at a child care establishment, health care institution, correctional facility, school, pharmacy, or shelter.

3. "Agency" means any board, commission, department, office, or other administrative unit of the federal government, the state, or a political subdivision of the state.

4. "Agent" means an organism that may cause a disease, either directly or indirectly.

5. "AIDS" means Acquired Immunodeficiency Syndrome.

6. "Airborne precautions" means, in addition to use of standard precautions:

a. Either:

i. Placing an individual in a private room with negative air-pressure ventilation, at least six air exchanges per hour, and air either:

(1) Exhausted directly to the outside of the
building containing the room, or

(2) Recirculated through a HEPA filtration
system before being returned to the
interior of the building containing the
room; or

ii. If the building in which an individual is located does not have an unoccupied room meeting the specifications in subsection (6)(a)(i):

(1) Placing the individual in a private room,
with the door to the room kept closed
when not being used for entering or
leaving the room, until the individual is
transferred to a health care institution that
has a room meeting the specifications in
subsection (6)(a)(i) or to the individual's
residence, as medically appropriate; and

(2) Ensuring that the individual is wearing a
mask covering the individual's nose and
mouth; and

b. Ensuring the use by other individuals, when entering the room in which the individual is located, of a device that is:

i. Designed to protect the wearer against inhalation of an atmosphere that may be harmful to the health of the wearer, and

ii. At least as protective as a National Institute for Occupational Safety and Health-approved N-95 respirator.

7. "Approved test for tuberculosis" means a Mantoux skin test or other test for tuberculosis recommended by the Centers for Disease Control and Prevention or the Tuberculosis Control Officer appointed under A.R.S. § 36-714.

8. "Arizona State Laboratory" means the part of the Department authorized by A.R.S. Title 36, Chapter 2, Article 2, and A.R.S. § 36-132(A)(11) that performs serological, microbiological, entomological, and chemical analyses.

9. "Average window period" means the typical time between exposure to an agent and the ability to detect infection with the agent in human blood.

10. "Barrier" means a mask, gown, glove, face shield, face mask, or other membrane or filter to prevent the transmission of infectious agents and protect an individual from exposure to body fluids.

11. "Body fluid" means semen, vaginal secretion, tissue, cerebrospinal fluid, synovial fluid, pleural fluid, peritoneal fluid, pericardial fluid, amniotic fluid, urine, blood, lymph, or saliva.

12. "Carrier" means an infected individual without symptoms who can spread the infection to a susceptible individual.

13. "Case" means an individual:

a. With a communicable disease whose condition is documented:

i. By laboratory results that support the presence of the agent that causes the disease;

ii. By a health care provider's diagnosis based on clinical observation; or

iii. By epidemiologic associations with the communicable disease, the agent that causes the disease, or toxic products of the agent;

b. Who has experienced diarrhea, nausea, or vomiting as part of an outbreak;

c. Who has died without apparent cause within 48 hours after experiencing a fever; or

d. Who has experienced a vaccinia-related adverse event.

14. "Case definition" means the disease-specific criteria that must be met for an individual to be classified as a case.

15. "Chief medical officer" means the senior health care provider in a correctional facility or that individual's designee who is also a health care provider.

16. "Child" means an individual younger than 18 years of age.

17. "Child care establishment" means:

a. A "child care facility," as defined in A.R.S. § 36-881;

b. A "child care group home," as defined in A.R.S. § 36-897;

c. A child care home registered with the Arizona Department of Education under A.R.S. § 46-321; or

d. A child care home certified by the Arizona Department of Economic Security under A.R.S. Title 46, Chapter 7, Article 1.

18. "Clinical signs and symptoms" means evidence of disease or injury that can be observed by a health care provider or can be inferred by the heath care provider from a patient's description of subjective complaints.

19. "Cohort room" means a room housing only individuals infected with the same agent and no other agent.

20. "Communicable disease" means an illness caused by an agent or its toxic products that arises through the transmission of that agent or its products to a susceptible host, either directly or indirectly.

21. "Communicable period" means the time during which an agent may be transmitted directly or indirectly:

a. From an infected individual to another individual;

b. From an infected animal, arthropod, or vehicle to an individual; or

c. From an infected individual to an animal.

22. "Confirmatory test" means a laboratory analysis, such as a Western blot analysis, approved by the U.S. Food and Drug Administration to be used after a screening test to diagnose or monitor the progression of HIV infection.

23. "Contact" means an individual who has been exposed to an infectious agent in a manner that may have allowed transmission of the infectious agent to the individual during the communicable period.

24. "Correctional facility" means any place used for the confinement or control of an individual:

a. Charged with or convicted of an offense,

b. Held for extradition, or

c. Pursuant to a court order for law enforcement purposes.

25. "Court-ordered subject" means a subject who is required by a court of competent jurisdiction to provide one or more specimens of blood or other body fluids for testing.

26. "Dentist" means an individual licensed under A.R.S. Title 32, Chapter 11, Article 2.

27. "Department" means the Arizona Department of Health Services.

28. "Designated service area" means the same as in A.A.C. R9-18-101.

29. "Diagnosis" means an identification of a disease by an individual authorized by law to make the identification.

30. "Disease" means a condition or disorder that causes the human body to deviate from its normal or healthy state.

31. "Emerging or exotic disease" means:

a. A new disease resulting from change in an existing organism;

b. A known disease not usually found in the geographic area or population in which it is found;

c. A previously unrecognized disease appearing in an area undergoing ecologic transformation; or

d. A disease reemerging as a result of a situation such as antimicrobial resistance in a known infectious agent, a breakdown in public health measures, or deliberate release.

32. "Entity" has the same meaning as "person" in A.R.S. § 1-215.

33. "Epidemiologic investigation" means the application of scientific methods to ascertain a diagnosis; identify risk factors for a disease; determine the potential for spreading a disease; institute control measures; and complete forms and reports such as communicable disease, case investigation, and outbreak reports.

34. "Fever" means a temperature of 101° F or higher.

35. "Food establishment" has the same meaning as in the document incorporated by reference in A.A.C. R9-8-107.

36. "Food handler" means:

a. A paid or volunteer full-time or part-time worker who prepares or serves food or who otherwise touches food in a food establishment; or

b. An individual who prepares food for or serves food to a group of two or more individuals in a setting other than a food establishment.

37. "Foodborne" means that food serves as a mode of transmission of an infectious agent.

38. "Guardian" means an individual who is invested with the authority and charged with the duty of caring for an individual by a court of competent jurisdiction.

39. "HBsAg" means hepatitis B surface antigen.

40. "Health care institution" has the same meaning as in A.R.S. § 36-401.

41. "Health care provider" means the same as in A.R.S. § 36-661.

42. "Health education" means supplying to an individual or a group of individuals:

a. Information about a communicable disease or options for treatment of a communicable disease, and

b. Guidance about methods to reduce the risk that the individual or group of individuals will become infected or infect other individuals.

43. "HIV" means Human Immunodeficiency Virus.

44. "HIV-related test" has the same meaning as in A.R.S. § 36-661.

45. "Infected" or "infection" means when an individual has an agent for a disease in a part of the individual's body where the agent may cause a disease.

46. "Infectious active tuberculosis" means pulmonary or laryngeal active tuberculosis in an individual, which can be transmitted from the infected individual to another individual.

47. "Infectious agent" means an agent that can be transmitted to an individual.

48. "Infant" means a child younger than 12 months of age.

49. "Isolate" means:

a. To separate an infected individual or animal from others to limit the transmission of infectious agents, or

b. A pure strain of an agent obtained from a specimen.

50. "Isolation" means separation, during the communicable period, of an infected individual or animal from others to limit the transmission of infectious agents.

51. "Laboratory report" means a document that:

a. Is produced by a laboratory that conducts a test or tests on a subject's specimen; and

b. Shows the outcome of each test, including personal identifying information about the subject.

52. "Local health agency" means a county health department, a public health services district, a tribal health unit, or a U.S. Public Health Service Indian Health Service Unit.

53. "Local health officer" means an individual who has daily control and supervision of a local health agency or the individual's designee.

54. "Medical examiner" means an individual:

a. Appointed as a county medical examiner by a county board of supervisors under A.R.S. § 11-592, or

b. Employed by a county board of supervisors under A.R.S. § 11-592 to perform the duties of a county medical examiner.

55. "Multi-drug resistant tuberculosis" means active tuberculosis that is caused by bacteria that are not susceptible to the antibiotics isoniazid and rifampin.

56. "Officer in charge" means the individual in the senior leadership position in a correctional facility or that individual's designee.

57. "Outbreak" means an unexpected increase in incidence of a disease, infestation, or sign or symptom of illness.

58. "Parent" means a biological or adoptive mother or father.

59. "Petition" means a formal written application to a court requesting judicial action on a matter.

60. "Pharmacy" has the same meaning as in A.R.S. § 32-1901.

61. "Physician" means an individual licensed as a doctor of:

a. Allopathic medicine under A.R.S. Title 32, Chapter 13;

b. Naturopathic medicine under A.R.S. Title 32, Chapter 14;

c. Osteopathic medicine under A.R.S. Title 32, Chapter 17; or

d. Homeopathic medicine under A.R.S. Title 32, Chapter 29.

62. "Physician assistant" has the same meaning as in A.R.S. § 32-2501.

63. "Pupil" means a student attending a school.

64. "Quarantine" means the restriction of activities of an individual or animal that has been exposed to a case or carrier of a communicable disease during the communicable period, to prevent transmission of the disease if infection occurs.

65. "Registered nurse practitioner" has the same meaning as in A.R.S. § 32-1601.

66. "Risk factor" means an activity or circumstance that increases the chances that an individual will become infected with or develop a communicable disease.

67. "School" means:

a. An "accommodation school," as defined in A.R.S. § 15-101;

b. A "charter school," as defined in A.R.S. § 15-101;

c. A "private school," as defined in A.R.S. § 15-101;

d. A "school," as defined in A.R.S. § 15-101;

e. A college or university;

f. An institution that offers a "private vocational program," as defined in A.R.S. § 32-3001; or

g. An institution that grants a "degree," as defined in A.R.S. § 32-3001, for completion of an educational program of study.

68. "Screening test" means a laboratory analysis approved by the U.S. Food and Drug Administration as an initial test to indicate the possibility that an individual is infected with a communicable disease.

69. "Sexual contact" means vaginal intercourse, anal intercourse, fellatio, or cunnilingus.

70. "Shelter" means:

a. A facility or home that provides "shelter care," as defined in A.R.S. § 8-201;

b. A "homeless shelter," as defined in A.R.S. § 16-121; or

c. A "shelter for victims of domestic violence," as defined in A.R.S. § 36-3001.

71. "Significant exposure" means the same as in A.R.S. § 32-3207.

72. "Standard precautions" means the use of barriers by an individual to prevent parenteral, mucous membrane, and nonintact skin exposure to body fluids and secretions other than sweat.

73. "Subject" means an individual whose blood or other body fluid has been tested or is to be tested.

74. "Submitting entity" means the same as in A.R.S. § 13-1415.

75. "Suspect case" means an individual whose medical history, signs, or symptoms indicate that the individual:

a. May have or is developing a communicable disease;

b. May have experienced diarrhea, nausea, or vomiting as part of an outbreak;

c. May have died without apparent cause within 48 hours after experiencing a fever; or

d. May have experienced a vaccinia-related adverse event.

76. "Syndrome" means a pattern of signs and symptoms characteristic of a disease.

77. "Test" means an analysis performed on blood or other body fluid to evaluate for the presence or absence of a disease.

78. "Test result" means information about the outcome of a laboratory analysis of a subject's specimen and does not include personal identifying information about the subject.

79. "Treatment" means a procedure or method to cure, improve, or palliate an illness or a disease.

80. "Tuberculosis control officer" means the same as in A.R.S. § 36-711.

81. "Unexplained death with a history of fever" means the demise of an individual who has had a fever within 48 hours before death and whose illness has not been diagnosed at the time of death.

82. "Vaccinia-related adverse event" means any of the reactions described in Exhibit I-A.

83. "Victim" means an individual on whom another individual is alleged to have committed a sexual offense, as defined in A.R.S. § 13-1415.

84. "Viral hemorrhagic fever" means disease characterized by fever and hemorrhaging and caused by a virus.

85. "Waterborne" means that water serves as a mode of transmission of an infectious agent.

86. "Working day" means the period from 8:00 a.m. to 5:00 p.m. on a Monday, Tuesday, Wednesday, Thursday, or Friday that is not a state holiday.